Clinical Isolates of Aspergillus Species Remain Fully Susceptible to Voriconazole in the Post-Voriconazole Era
- 1 September 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (9) , 3444-3446
- https://doi.org/10.1128/aac.00629-08
Abstract
We studied the activity of voriconazole against 400 clinical strains of Aspergillus from the pre-voriconazole (1999 to 2002) and post-voriconazole (2003 to 2007) periods. Although the mean MICs of strains from the post-voriconazole period were slightly higher (0.39 versus 0.57 μg/ml; P < 0.001), all strains were susceptible to voriconazole and presented an MIC of ≤2 μg/ml.Keywords
This publication has 14 references indexed in Scilit:
- In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida , Aspergillus , Fusarium , and Scedosporium SpeciesAntimicrobial Agents and Chemotherapy, 2008
- A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A AlterationsAntimicrobial Agents and Chemotherapy, 2007
- Multiple-Triazole–Resistant AspergillosisNew England Journal of Medicine, 2007
- Susceptibility of environmental versus clinical strains of pathogenic AspergillusInternational Journal of Antimicrobial Agents, 2007
- Multi-azole resistance in Aspergillus fumigatusInternational Journal of Antimicrobial Agents, 2006
- Antifungal Susceptibility of 596 Aspergillus fumigatus Strains Isolated from Outdoor Air, Hospital Air, and Clinical Samples: Analysis by Site of IsolationAntimicrobial Agents and Chemotherapy, 2005
- Aspergillus fumigatusVariant with Decreased Susceptibility to Multiple AntifungalsAntimicrobial Agents and Chemotherapy, 2004
- Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patientsJournal of Medical Microbiology, 2004
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Nationwide Survey of In Vitro Activities of Itraconazole and Voriconazole against Clinical Aspergillus fumigatus Isolates Cultured between 1945 and 1998Journal of Clinical Microbiology, 2002